TransMedics secures full FDA IDE approval for its OCS ENHANCE Heart trial, clearing a key hurdle and advancing its push to expand heart transplant use.

While February 2nd twenty years ago is listed on Wikipedia as the founding date -- the day when, according to Mike Milinkovich, the first official press release was issued -- the Foundation already ...

The Laramie County Sheriff’s Office has launched a criminal investigation to determine whether checks distributed to Wyoming ...

First podium presentation of IDE Clinical Trial Data of Novel Embolic Device to Treat Cancer The SIR clinical community ...

The first beta of Android 17 is now available, and it features a change in how the Android development team shares new releases of Android to developers.

Gemini has a lot of promise, but Claude wins hands down.

Rust is one of the newest programming languages, and it can change how you see code.

FDA grants Breakthrough Device Designation to BioAgilytix’s anti-AAV antibody assay supporting Lexeo’s gene therapy for ...

The 45-day post-implantation results support use of a next-generation device in people with atrial fibrillation, but caution is advised until longer-term results are available.

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 28, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") ...

Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.

OpenClaw rebranded from Cloudbot to Moldbot after a naming dispute, and now targets non-developers with simpler personal AI agents.